NEW YORK (GenomeWeb) – Thermo Fisher Scientific said yesterday that it has priced an offering of $1.5 billion aggregate principal amount of senior notes.

The company is aiming to raise $750 million through the issuance of its 3.2% senior notes due 2027 and $750 million aggregate principal amount through the issuance of its 4.1% senior notes due 2047.

The issuance of the notes is expected to close on Aug. 14, and the notes will pay interest on a semi-annual basis.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.